Correlation Between Eliem Therapeutics and Adverum Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Adverum Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Adverum Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Adverum Biotechnologies, you can compare the effects of market volatilities on Eliem Therapeutics and Adverum Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Adverum Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Adverum Biotechnologies.
Diversification Opportunities for Eliem Therapeutics and Adverum Biotechnologies
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Eliem and Adverum is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Adverum Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adverum Biotechnologies and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Adverum Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adverum Biotechnologies has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Adverum Biotechnologies go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Adverum Biotechnologies
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Adverum Biotechnologies. In addition to that, Eliem Therapeutics is 1.26 times more volatile than Adverum Biotechnologies. It trades about -0.25 of its total potential returns per unit of risk. Adverum Biotechnologies is currently generating about -0.19 per unit of volatility. If you would invest 776.00 in Adverum Biotechnologies on August 30, 2024 and sell it today you would lose (131.00) from holding Adverum Biotechnologies or give up 16.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Eliem Therapeutics vs. Adverum Biotechnologies
Performance |
| Timeline |
| Eliem Therapeutics |
| Adverum Biotechnologies |
Eliem Therapeutics and Adverum Biotechnologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Adverum Biotechnologies
The main advantage of trading using opposite Eliem Therapeutics and Adverum Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Adverum Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adverum Biotechnologies will offset losses from the drop in Adverum Biotechnologies' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Adverum Biotechnologies vs. Uniqure NV | Adverum Biotechnologies vs. Rocket Pharmaceuticals | Adverum Biotechnologies vs. Rhythm Pharmaceuticals | Adverum Biotechnologies vs. Solid Biosciences LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |